
### [NCIT:C26818](http://purl.obolibrary.org/obo/NCIT_C26818)
**Label:** Lip Disorder

**Subclasses:** [NCIT:C5877](http://purl.obolibrary.org/obo/NCIT_C5877) (Stage II Lip Cancer AJCC v6 and v7), [NCIT:C5878](http://purl.obolibrary.org/obo/NCIT_C5878) (Stage III Lip Cancer AJCC v6 and v7), [NCIT:C5879](http://purl.obolibrary.org/obo/NCIT_C5879) (Stage IV Lip Cancer AJCC v6 and v7), [NCIT:C8209](http://purl.obolibrary.org/obo/NCIT_C8209) (Stage IV Lip Basal Cell Carcinoma), [NCIT:C8205](http://purl.obolibrary.org/obo/NCIT_C8205) (Stage III Lip Basal Cell Carcinoma), [NCIT:C4588](http://purl.obolibrary.org/obo/NCIT_C4588) (Stage 0 Lip Cancer AJCC v6 and v7), [NCIT:C5876](http://purl.obolibrary.org/obo/NCIT_C5876) (Stage I Lip Cancer AJCC v6 and v7), [NCIT:C3591](http://purl.obolibrary.org/obo/NCIT_C3591) (Benign Lip Neoplasm), [NCIT:C8542](http://purl.obolibrary.org/obo/NCIT_C8542) (Metastatic Malignant Neoplasm in the Lip), [NCIT:C5893](http://purl.obolibrary.org/obo/NCIT_C5893) (Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7), [NCIT:C3490](http://purl.obolibrary.org/obo/NCIT_C3490) (Lip Carcinoma), [NCIT:C8201](http://purl.obolibrary.org/obo/NCIT_C8201) (Stage II Lip Basal Cell Carcinoma), [NCIT:C8014](http://purl.obolibrary.org/obo/NCIT_C8014) (Lip Basal Cell Carcinoma), [NCIT:C8213](http://purl.obolibrary.org/obo/NCIT_C8213) (Recurrent Lip Basal Cell Carcinoma), [NCIT:C8197](http://purl.obolibrary.org/obo/NCIT_C8197) (Stage I Lip Basal Cell Carcinoma), [NCIT:C7485](http://purl.obolibrary.org/obo/NCIT_C7485) (Malignant Lip Neoplasm), [NCIT:C4042](http://purl.obolibrary.org/obo/NCIT_C4042) (Lip Squamous Cell Carcinoma), [NCIT:C3191](http://purl.obolibrary.org/obo/NCIT_C3191) (Lip Neoplasm), [NCIT:C26818](http://purl.obolibrary.org/obo/NCIT_C26818) (Lip Disorder), 

**Class expressions from DL-Learner:**

- [NCIT:C26818](http://purl.obolibrary.org/obo/NCIT_C26818) (Lip Disorder) 97.50%
- [NCIT:C3191](http://purl.obolibrary.org/obo/NCIT_C3191) (Lip Neoplasm) 95.00%
- [NCIT:C7485](http://purl.obolibrary.org/obo/NCIT_C7485) (Malignant Lip Neoplasm) 90.00%
- [NCIT:C3490](http://purl.obolibrary.org/obo/NCIT_C3490) (Lip Carcinoma) 85.00%
- [NCIT:C132736](http://purl.obolibrary.org/obo/NCIT_C132736) (Lip and Oral Cavity Cancer by AJCC v6 and v7 Stage) and [NCIT:C7485](http://purl.obolibrary.org/obo/NCIT_C7485) (Malignant Lip Neoplasm) 75.00%
- [NCIT:C132736](http://purl.obolibrary.org/obo/NCIT_C132736) (Lip and Oral Cavity Cancer by AJCC v6 and v7 Stage) and [NCIT:C3490](http://purl.obolibrary.org/obo/NCIT_C3490) (Lip Carcinoma) 75.00%
- [NCIT:C132736](http://purl.obolibrary.org/obo/NCIT_C132736) (Lip and Oral Cavity Cancer by AJCC v6 and v7 Stage) and [NCIT:C3191](http://purl.obolibrary.org/obo/NCIT_C3191) (Lip Neoplasm) 75.00%
- [NCIT:C132736](http://purl.obolibrary.org/obo/NCIT_C132736) (Lip and Oral Cavity Cancer by AJCC v6 and v7 Stage) and [NCIT:C26818](http://purl.obolibrary.org/obo/NCIT_C26818) (Lip Disorder) 75.00%
- [NCIT:C8014](http://purl.obolibrary.org/obo/NCIT_C8014) (Lip Basal Cell Carcinoma) 67.50%
- [NCIT:C2921](http://purl.obolibrary.org/obo/NCIT_C2921) (Skin Basal Cell Carcinoma) and [NCIT:C9316](http://purl.obolibrary.org/obo/NCIT_C9316) (Malignant Oral Neoplasm) 67.50%
- [NCIT:C2921](http://purl.obolibrary.org/obo/NCIT_C2921) (Skin Basal Cell Carcinoma) and [NCIT:C9315](http://purl.obolibrary.org/obo/NCIT_C9315) (Lip and Oral Cavity Carcinoma) 67.50%
- [NCIT:C2921](http://purl.obolibrary.org/obo/NCIT_C2921) (Skin Basal Cell Carcinoma) and [NCIT:C8989](http://purl.obolibrary.org/obo/NCIT_C8989) (Oral Neoplasm) 67.50%
- [NCIT:C2921](http://purl.obolibrary.org/obo/NCIT_C2921) (Skin Basal Cell Carcinoma) and [NCIT:C7485](http://purl.obolibrary.org/obo/NCIT_C7485) (Malignant Lip Neoplasm) 67.50%
- [NCIT:C2921](http://purl.obolibrary.org/obo/NCIT_C2921) (Skin Basal Cell Carcinoma) and [NCIT:C3490](http://purl.obolibrary.org/obo/NCIT_C3490) (Lip Carcinoma) 67.50%
- [NCIT:C2921](http://purl.obolibrary.org/obo/NCIT_C2921) (Skin Basal Cell Carcinoma) and [NCIT:C3191](http://purl.obolibrary.org/obo/NCIT_C3191) (Lip Neoplasm) 67.50%


